- Home
- AQST vs MG Comparison
AQST vs MG Comparison
Compare AQST & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- MG
- Stock Information
- Founded
- AQST 2004
- MG 1978
- Country
- AQST United States
- MG United States
- Employees
- AQST N/A
- MG N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- MG Military/Government/Technical
- Sector
- AQST Health Care
- MG Consumer Discretionary
- Exchange
- AQST Nasdaq
- MG Nasdaq
- Market Cap
- AQST 285.4M
- MG 278.5M
- IPO Year
- AQST 2018
- MG 2009
- Fundamental
- Price
- AQST $3.10
- MG $9.61
- Analyst Decision
- AQST Strong Buy
- MG Hold
- Analyst Count
- AQST 8
- MG 1
- Target Price
- AQST $10.38
- MG $11.00
- AVG Volume (30 Days)
- AQST 1.5M
- MG 155.2K
- Earning Date
- AQST 03-04-2025
- MG 03-05-2025
- Dividend Yield
- AQST N/A
- MG N/A
- EPS Growth
- AQST N/A
- MG N/A
- EPS
- AQST N/A
- MG 0.36
- Revenue
- AQST $58,900,000.00
- MG $738,983,000.00
- Revenue This Year
- AQST $18.44
- MG $6.49
- Revenue Next Year
- AQST N/A
- MG $2.75
- P/E Ratio
- AQST N/A
- MG $27.04
- Revenue Growth
- AQST 22.56
- MG 6.85
- 52 Week Low
- AQST $2.24
- MG $7.45
- 52 Week High
- AQST $6.23
- MG $12.44
- Technical
- Relative Strength Index (RSI)
- AQST 34.77
- MG 62.97
- Support Level
- AQST $2.96
- MG $8.78
- Resistance Level
- AQST $3.30
- MG $9.67
- Average True Range (ATR)
- AQST 0.21
- MG 0.25
- MACD
- AQST 0.01
- MG 0.09
- Stochastic Oscillator
- AQST 16.87
- MG 93.68
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.